- 020 3313 1178
Jennifer McKenzie, secretary
After qualifying in medicine at St Thomas' Hospital Medical School in London, Dr Robina Coker completed postgraduate training with posts at the Royal Brompton, London Chest, Bart's, Charing Cross and Whipps Cross hospitals. Her PhD (undertaken at the National Heart & Lung Institute and University College, London) focused on the molecular mechanisms underlying the development of lung fibrosis. Since her appointment at Hammersmith Hospital in 1999 she has developed sub-specialty interests in interstitial lung disease, and in air travel and lung disease. In addition to her work as consultant and honorary senior lecturer in respiratory medicine she is currently clinical director of the NIHR Clinical Research Network, north west London. This has an annual budget of over £14 million and supports clinical trials across north west London.
Respiratory medicine, sub-specialty expertise in interstitial lung disease (including sarcoidosis, idiopathic pulmonary fibrosis, and connective tissue disease-related interstitial lung disease)., sub-specialty expertise in lung disease and air travel
Research & publications
Interstitial lung disease, air travel and lung disease
Thillai M, Chang W, Chaudhuri N, Forrest I, Ho Ling-Pei, Lines S, Maher T, Spencer LG, Spiteri M, Coker R (2019) Sarcoidosis in the UK: insights from British Thoracic Society registry data. BMJ Open Respiratory Research 6:e000357. doi:10.1136/bmjresp-2018-000357
Coker R K (2017) Travelling by air with lung disease: what do doctors and their patients need to know? Resp Dis in Pract; 25:2 Sarcoidosis in the UK: insights from British Thoracic Society registry data.
Farah Z, Beasley V E, Berry M, Coker R K, Kon O M (2014) Two cases of culture proven Mycobacterium tuberculosis presenting with a broad-complex tachycardia and non-caseating granulomas. Resp Med Case Reports,12: 41-43
Josephs LK, Coker R K, Thomas K (2013) Managing patients with stable respiratory disease planning air travel: a primary care summary of the British Thoracic Society recommendations. Prim Care Respir J 22: 234-238
Shrikrishna D, Howard L, Coker R K (2013) Authors' response to: How should we best determine the need for in-flight oxygen in patients with pulmonary arterial hypertension. Thorax 68: 680-1
Ahmedzai S, Balfour-Lynn I M, Bewick T, Buchdahl R, Coker R K (chair of BTS Air Travel Working Party), Cummin AR, Gradwell DP, Howard L, Innes JA, Johnson AOC et al (2011) Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax 66: 1-30
Shrikrishna D, Coker R K (2011) Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax 66: 831-833
Coker R K (2009) Management strategies for pulmonary sarcoidosis. Ther Clin Risk Manag 5: 575-584
Coker R K (2008) When should we treat pulmonary sarcoidosis, and how? Minerva Pneumol 47: 9-48